Doctor Robert L. Kirby, MD works in the field of Oncology. He graduated from University of Kansas School of Medicine. He has 2 awards "Meaningful Use Stage 1 Certification" and "Super Doctor". Robert L. Kirby, MD is a published physician. He published 2 publications, including: 'Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research...' He accepts Medicare payments and is listed with Medicare.gov.
NPI NUMBER | 1104869544 | |
NPPES Provider LastName | KIRBY | |
NPPES Provider FirstName | ROBERT | |
NPPES Provider ZIPCode | 750757753 | |
NPPES Provider State | TX | |
Specialty Description | Medical Oncology | |
Total Claim Count | 1225.0 | |
Distinct Opioid Count | 4.0 | |
Opioid Claim Count | 163.0 | |
Percent Opioid Claims | 13.31 |
National Provider Identifier [NPI] | 1104869544 |
Last Name Of The Provider | KIRBY |
First Name Of The Provider | ROBERT |
View All |
Dr. Gerardo H. Trillo, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Christopher T. Stokoe, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Charles K. Connor, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Ruben A. Saez, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Scott A. Stone, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Virginia M. Kinsella, MD
This Doctor is OpenDoctor Recommended. |